Table: Towa Pharmaceutical - 9-MTH group results

TOWA PHARMACEUTICAL

12/02/2021 06:01

Feb 12 (Reuters)- 
             Towa Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2020        Dec 31, 2019     Mar 31, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              115.25               84.41           153.00    
                   (+36.5 pct)         (+7.8 pct)       (+38.6 pct) 
  Operating           14.79               14.12            19.50    
                   (+4.7 pct)          (+18.1 pct)      (+20.8 pct) 
  Recurring           13.05               15.43            17.50    
                   (-15.5 pct)         (+6.0 pct)       (-16.6 pct) 
  Net                  9.45               10.97            12.60    
                   (-13.9 pct)         (+4.9 pct)       (-13.1 pct) 
  EPS              191.96 yen          222.92 yen       256.02 yen  
  EPS Diluted      187.48 yen          206.19 yen                   
  Ann Div                               44.00 yen        44.00 yen  
  -Q2 div           22.00 yen           22.00 yen                   
  -Q4 div                               22.00 yen        22.00 yen  
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T